CPC-211: Began Phase I trial

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-211 small molecule stimulator of anaerobic glycolysis, which shunts production of lactic acid by oxygen-starved cells toward productio...